About Neuros Medical
Neuros Medical is a private company based in Aliso Viejo, California. It has reported $153,974,469 raised in 11 offerings on Form D since October 2009. Its chief executive is David Veino.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 9, 2025 | Aug 6, 2025 | $55,999,997of $64.9M target | 28 | $1.9M | EquityRule 506(b) | Form D ↗ |
| Jun 16, 2023 | Sep 25, 2023 | $20,000,000of $20.0M target | 41 | $487K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Nov 15, 2022 | Dec 19, 2022 | $8,229,699of $10.0M target | 40 | $205K | DebtRule 506(b) | Form D ↗ |
| Oct 27, 2020 | Nov 3, 2020 | $36,981,418of $42.7M target | 24 | $1.5M | EquityRule 506(b) | Form D ↗ |
| May 27, 2020 | Jun 10, 2020 | $2,200,000of $5.5M target | 5 | $440K | DebtRule 506(b) | Form D ↗ |
| Oct 11, 2019 | Oct 22, 2019 | $2,385,759of $9.2M target | 4 | $596K | EquityRule 506(b) | Form D ↗ |
| Aug 3, 2017 | Aug 16, 2017 | $22,634,257of $22.6M target | 27 | $838K | EquityRule 506(c) | Form D ↗ |
| Not yet | May 12, 2016 | $0of $6.0M target | 0 | — | DebtRule 506(c) | Form D ↗ |
| Jan 22, 2013 | Feb 19, 2013 | $1,750,000fully sold | 11 | $159K | Debt06 | Form D ↗ |
| Nov 22, 2011 | Jun 7, 2012amended Feb 11, 2013 | $2,508,310of $4.0M target | 29 | $86,493 | Equity06 | Form D/A ↗1 earlier filing |
| Aug 20, 2009 | Oct 19, 2009 | $1,285,029of $1.8M target | 11 | $116K | Equity06 | Form D ↗ |
| Total, 11 offerings | $153,974,469 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Neuros Medical's Form D filed Aug 6, 2025.
Earlier filings also listed Thomas Wilder (executive officer and director, last listed Sep 2023), Anthony Natale (director, last listed Sep 2023), Jon Snyder (director, president, treasurer, secretary and ceo, last listed Aug 2017), Alan Kaganov (director, last listed Aug 2017), Stephen Haynes (director, last listed May 2016), Scott Drees (director, last listed May 2016), Robert Centa (chief financial officer, last listed May 2016) and Joseph Jankowski (director, last listed May 2016).